BTG Pactual Global Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

BTG Pactual Global Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,838	Closed	-$219K	–	43
2018 Q3	$219K	Sell	2,838 -5,748	-67%	-$462K	0.09%	56
2018 Q2	$723K	Buy	8,586 +607	+8%	+$52.9K	0.21%	46
2018 Q1	$653K	Sell	7,979 -325	-4%	-$25.1K	0.18%	46
2017 Q4	$475K	Buy	8,304 +281	+4%	+$17.7K	0.17%	40
2017 Q3	$536K	Sell	8,023 -337	-4%	-$20.2K	0.17%	48
2017 Q2	$430K	Buy	8,360 +2,058	+33%	+$105K	0.12%	56
2017 Q1	$368K	Buy	+6,302	New	+$302K	0.13%	57

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BTG Pactual Global Asset Management's AGIO Position: Q4 2018 in Review

BTG Pactual Global Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2018, closing a stake of 2,838 shares — an estimated $219K sold.

BTG Pactual Global Asset Management first reported a position in AGIO in Q1 2017 and held it in 7 quarters. The position peaked at $723K in Q2 2018. 196 funds tracked by Wall St. Rank hold AGIO as of Q4 2018.

BTG Pactual Global Asset Management reported no remaining Agios Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
BTG Pactual Global Asset Management sold 2,838 Agios Pharmaceuticals shares in Q4 2018, an estimated $219K.
BTG Pactual Global Asset Management first reported a position in Agios Pharmaceuticals in Q1 2017 and held it in 7 quarters.
BTG Pactual Global Asset Management's Agios Pharmaceuticals position peaked at $723K in Q2 2018.
196 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2018.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.